InvestorsHub Logo
Followers 10
Posts 605
Boards Moderated 0
Alias Born 06/30/2014

Re: None

Sunday, 12/08/2019 5:43:27 AM

Sunday, December 08, 2019 5:43:27 AM

Post# of 513
Seeking Alpha today: Same guy who wrote REL 1017 would fail phase 2 THE DAY BEFORE THE DATA WAS RELEASED!

Don't Be Fooled By
Relmada's Clinical
Data Readout
Dec. 08, 2019 5-12 AM ET | Relmada Therapeutics, Inc. (RLMD)
Summary
• REL-1017 saw superb Phase 2 results with 40% reduction vs. placebo on the HAM-D scale measuring patients' depression.
• The market seems to buy into the results, sending shares of RLMD into a massive rally since its recent press release.
• On a deeper dive, however, the clinical data may be deceiving in the context of a critical design oversight in REL-1017's investigation.....

https://seekingalpha.com/article/4311226-dont-be-fooled-relmadas-clinical-data-readout

—-This link always takes me to portfolio, you’ll have to look it up yourselves, sorry
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RLMD News